Table 3.
Change in UPDRS Total and Motor score after 12 months of treatment with safinamide
12-months FUP vs baseline (N = 363) |
||
---|---|---|
UPDRS: Change in total scores (subscales I, II, and III) | < = −4.3 points | 137 (37.7%) |
> −4.3 points* | 210 (57.9%) | |
NA | 16 (4.4%) | |
UPDRS Part III: Change in motor examination score | < = −2.5 points | 156 (43.0%) |
> −2.5 points* | 197 (54.3%) | |
NA | 10 (2.8%) |
FUP Follow-up; NA Not available; *An increase in UPDRS Total score > 4.3 points and in UPDRS Part III > 2.5 points was considered as clinically significant according to Shulman et al. [14]. UPDRS, Unified Parkinson’s Disease Rating Scale